Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adial Pharmaceuticals Inc (NQ: ADIL )

2.350 USD +0.300 (+14.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 214,893
Open 2.020
Bid (Size) 2.140 (4)
Ask (Size) 2.360 (3)
Prev. Close 2.050
Today's Range 1.980 - 2.380
52wk Range 1.140 - 4.000
Shares Outstanding 17,269,877
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adial Founder and Chief Medical Officer Dr. Bankole Johnson Featured Guest on The Black News Channel
Discusses long-term effects of COVID-19 pandemic on mental health and addiction 
From GlobeNewswire News Releases
Adial Announces Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share
From GlobeNewswire News Releases

Performance

YTD
+35.84%
+35.84%
1 Month
+7.31%
+7.31%
3 Month
-26.33%
-26.33%
6 Month
+36.63%
+36.63%
1 Year
+72.79%
+72.79%

More News

Read More
Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion
From GlobeNewswire News Releases
Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants
From GlobeNewswire News Releases
Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
From GlobeNewswire News Releases
Adial to File Fast Track Application for AD04 with the FDA
From GlobeNewswire News Releases
Adial Pharmaceuticals Closes Acquisition of Purnovate
From ACCESSWIRE
Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
From ACCESSWIRE
Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
From ACCESSWIRE
Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory
From ACCESSWIRE
Adial Pharmaceuticals Schedules Business Update Conference Call to Discuss Planned Acquisition of Purnovate and other Recent Developments
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.